circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway.

Wu G, Zhou W, Lin X, Sun Y, Li J, Xu H, Shi P, Gao L, Tian X

Open source

DOI
10.1016/j.omtn.2019.11.037
Published
2020 Mar 6
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2019.11.037,
  title = {circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway.},
  author = {Wu G and Zhou W and Lin X and Sun Y and Li J and Xu H and Shi P and Gao L and Tian X},
  year = {2020},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2019.11.037},
  url = {https://doi.org/10.1016/j.omtn.2019.11.037}
}

RIS

TY  - JOUR
TI  - circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway.
AU  - Wu G
AU  - Zhou W
AU  - Lin X
AU  - Sun Y
AU  - Li J
AU  - Xu H
AU  - Shi P
AU  - Gao L
AU  - Tian X
PY  - 2020
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2019.11.037
UR  - https://doi.org/10.1016/j.omtn.2019.11.037
ER  - 

APA

G, W., W, Z., X, L., Y, S., J, L., H, X., P, S., L, G., & X, T. (2020). circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2019.11.037

Source records